New technology for treating inoperable liver tumors
Feasibility of a Multi-Phase Algorithmic Non-Thermal Ablation Technology for the Treatment of Inoperable Tumors
This study is testing a new, gentle treatment called PACE that uses quick electrical pulses to help destroy hard-to-reach liver tumors, and it's designed for patients whose tumors can't be removed with surgery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gradient Medical, INC. NIH-funded |
| Lab location | 1 site (Cary, United States) |
| Project ID | NIH-10547371 on NIH RePORTER |
What this research studies
This research investigates a novel minimally invasive technique called Phased Algorithmically Controlled Electrotherapy (PACE) for treating inoperable liver tumors. The approach uses ultrashort high-intensity electrical pulses to disrupt cancer cells, leading to cell death. The study aims to develop a specialized pulse generation system and assess how effectively it can target liver tumors. Patients with liver tumors that cannot be surgically removed may benefit from this innovative treatment method.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with inoperable liver tumors who are not suitable for surgical resection.
Not a fit: Patients with operable liver tumors or those who have other medical conditions that preclude them from receiving this type of treatment may not benefit.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for patients with inoperable liver tumors, potentially improving survival rates.
How similar studies have performed: While this approach is innovative, similar techniques using electrical pulses for tumor treatment have shown promise in preliminary studies.
Where this research is happening
Cary, United States
- Gradient Medical, INC. — Cary, United States (Active)
Researchers
- Principal investigator: Fong, Jordan — Gradient Medical, INC.
- Study coordinator: Fong, Jordan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.